DSGN
Design Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.64
+3.20%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.38
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 3, 2026
- EPS actual
- -$0.32
- EPS estimate
- -$0.34
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +16.2%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.34 | -$0.32 | Beat 7.06% | — |
| Apr 28, 2026 | -$0.36 | -$0.29 | Beat 19.44% | — |
| Mar 9, 2026 | -$0.38 | -$0.28 | Beat 26.57% | — |
| Nov 5, 2025 | -$0.34 | -$0.30 | Beat 11.76% | — |
| Aug 7, 2025 | -$0.32 | -$0.34 | Miss -6.25% | — |
| Mar 10, 2025 | -$0.28 | -$0.24 | Beat 14.29% | — |
| Nov 7, 2024 | -$0.26 | -$0.23 | Beat 11.54% | — |
| Mar 19, 2024 | -$0.32 | -$0.21 | Beat 34.38% | $838.0K |
| Nov 13, 2023 | -$0.42 | -$0.28 | Beat 33.33% | — |
| Aug 14, 2023 | -$0.41 | -$0.36 | Beat 12.20% | — |
| Mar 14, 2023 | -$0.34 | -$0.31 | Beat 8.82% | — |
| Nov 3, 2022 | -$0.28 | -$0.32 | Miss -14.29% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026